Article record

III型家庭睡眠呼吸暂停检测的技术性能及自动与人工判读一致性：一项来自沙特阿拉伯的单中心研究

Technical Performance and Automated-manual Scoring Agreement in Type III Home Sleep Apnea Testing: A Single-center Study from Saudi Arabia.

临床研究咽喉科IF 2Q2

文献信息

PMID	42974588
原文	在 PubMed 查看原文 ↗
发表日期	2026
作者	Sultan Aldhabei 查看其他 10 位作者 Raghad Alhajaji；Salih A Aleissi；Hamza O Dhafar；Samar Z Nashwan；Mohammad Alrashed；Abdullah Aldhuwaihy；Talal Alghadir；Mohammed H Alhumud；Ahmed T Alhawamdeh；Ahmed S Bahammam
作者单位	Department of Medicine, College of Medicine, Najran University, Najran, Saudi Arabia. 查看其他 5 条单位信息 Sleep Medicine Department, King Saud University Medical City, Riyadh, Saudi Arabia.；Department of Medicine, College of Medicine, University Sleep Disorders Center, King Saud University, Riyadh, Saudi Arabia.；Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.；Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.；The Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
期刊	Saudi journal of medicine & medical sciences
SCI 分区	Q2
IF	2
研究类型	临床研究 · 临床
所属专科	咽喉科

中文摘要

背景： 阻塞性睡眠呼吸暂停（OSA）是一种患病率高的疾病，具有显著的健康风险。家庭睡眠呼吸暂停检测（HSAT）是诊断OSA的一种具有成本效益的替代实验室多导睡眠监测的方法。
目的： 评估III型HSAT在OSA验前概率高的沙特人群中技术性能及自动与人工判读的一致性，并建立本地性能基线，以供未来多中心及跨区域比较参考。
方法： 这项回顾性研究纳入在沙特阿拉伯利雅得一家三级睡眠中心接受III型HSAT、中度至重度OSA验前概率高的成人。自动HSAT记录（Nox T3设备）由一名设盲的睡眠技师重新进行人工判读。关键结局包括技术成功率以及自动与人工判读呼吸指标之间的一致性。
结果： 共纳入173名参与者，其中128名（74.4%）患有OSA。HSAT技术成功率为90.7%。自动呼吸暂停低通气指数与人工判读显示高度总体一致性（CCC = 0.919；95% CI：0.893-0.940），平均偏倚极小。呼吸暂停指数（CCC = 0.993；95% CI：0.990-0.995）和氧减饱和度指数（CCC = 0.973；95% CI：0.964-0.980）显示极好的一致性，而低通气指数显示中等一致性（CCC = 0.820；95% CI：0.764-0.864），自动判读存在轻度低估。在技术失败的病例中，鼻气流的信号质量最差（均值 ± 标准差，58.4% ± 27.4%），其次是脉搏血氧饱和度（86.7% ± 25.1%）。
结论： 在沙特阿拉伯成人中，III型HSAT具有较高的技术成功率，且自动与人工判读之间总体一致性良好。这些发现支持将HSAT作为经过适当选择、OSA验前概率高的成人中可靠的诊断替代方法。

英文摘要

BACKGROUND: Obstructive sleep apnea (OSA) is a prevalent disorder that carries significant health risks. Home sleep apnea testing (HSAT) is a cost-effective alternative to in-lab polysomnography for diagnosing OSA.
OBJECTIVES: To evaluate the technical performance and automated-manual scoring agreement of type III HSAT in a Saudi population with a high pretest probability of OSA, and to establish a local performance baseline that can inform future multicenter and cross-regional comparisons.
METHODS: This retrospective study included adults with a high pretest probability of moderate-severe OSA who underwent type III HSAT at a tertiary sleep center in Riyadh, Saudi Arabia. Automated HSAT recordings (Nox T3 device) were re-scored manually by a blinded sleep technologist. Key outcomes included technical success and agreement between automated and manual scoring of respiratory indices.
RESULTS: A total of 173 participants were included, of which 128 (74.4%) had OSA. HSAT was technically successful in 90.7% of cases. Automated apnea-hypopnea index demonstrated high overall concordance with manual scoring (CCC = 0.919; 95% CI: 0.893-0.940), with minimal mean bias. The apnea index (CCC = 0.993; 95% CI: 0.990-0.995) and oxygen desaturation index (CCC = 0.973; 95% CI: 0.964-0.980) demonstrated excellent concordance, while the hypopnea index showed moderate concordance (CCC = 0.820; 95% CI: 0.764-0.864) with modest automated underestimation. In technically failed cases, nasal airflow showed the poorest signal quality (mean ± SD, 58.4% ± 27.4%) followed by pulse oximetry (86.7% ± 25.1%).
CONCLUSION: Among adults from Saudi Arabia, type III HSAT had a high technical success rate and strong overall agreement between automated and manual scoring. These findings support the use of HSAT as a reliable diagnostic alternative in appropriately selected adults with a high pretest probability of OSA.